Value20202021202220232024TTMCash from investing activities4.41 M5.37 M2.95 M5.89 M01.17 MCash from financing activities78.12 M70.85 M34.06 M26.08 M11.27 M19.46 MFree cash flow32.91 M48.3 M61.99 M49.36 M11.41 M5.54 M
Mustang Bio Inc
Mustang Bio is an American clinical-stage biopharmaceutical company founded in 2015 and headquartered in Worcester, MA, U.S. Operating as a partner company of Fortress Biotech, Mustang Bio develops CAR-T immunotherapies and gene therapies for multiple diseases, including hematologic cancers, solid tumors, and X-linked severe combined immunodeficiency.